PLEASANTON, CA--(Marketwire - August 14, 2008) - Lipid Sciences, Inc. (NASDAQ: LIPD) today reported financial results for the second quarter of 2008. For the three months ending June 30, 2008, the Company reported a net loss of $2.0 million, or $0.05 per share on a basic and diluted basis. This compares with a net loss of $2.7 million, or $0.07 per share, on a basic and diluted basis, for the same period in 2007. The financial results for the second quarter of 2007, included revenue of $137,000 related to a collaborative research agreement entered into with Elanco Animal Health in November 2006.
